BioSymetrics is a drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and precision medicines. It develops a Contingent-AI platform to address bias detection and correction during the pre-processing stages of machine learning and identify additional feature sets for analysis.